{"id":27223,"date":"2025-03-25T14:43:02","date_gmt":"2025-03-25T21:43:02","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=27223"},"modified":"2025-04-03T13:26:10","modified_gmt":"2025-04-03T20:26:10","slug":"ivig-for-autoimmune-mucocutaneous-blistering-diseases","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\/","title":{"rendered":"IgIV para enfermedades ampollosas mucocut\u00e1neas autoinmunes"},"content":{"rendered":"<p><a href=\"https:\/\/www.medicaljournals.se\/acta\/content\/html\/10.2340\/00015555-1471\">Investigaci\u00f3n<\/a> ha demostrado que <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig\/\">IgIV<\/a> es una opci\u00f3n de tratamiento prometedora para pacientes con <a href=\"https:\/\/utswmed.org\/conditions-treatments\/autoimmune-blistering-skin-diseases\/#:~:text=Autoimmune%20blistering%20skin%20diseases%20are,the%20skin%20and%20mucous%20membranes.\">enfermedades ampollosas mucocut\u00e1neas autoinmunes<\/a> (AMBD), un grupo de afecciones que causan ampollas dolorosas, llagas y, a veces, cicatrices en la piel o las membranas mucosas.\u00a0<\/p>\n\n\n\n<div  id=\"call-to-action-d78f07af6932a6e4728c4d95046a606c\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga su dosis de IgIV\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tInfusi\u00f3n en casa\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p>Anteriormente, se utilizaban terapias est\u00e1ndar como corticosteroides y agentes inmunosupresores para tratar las enfermedades ampollosas mucocut\u00e1neas autoinmunes. Sin embargo, estas terapias no ofrec\u00edan resultados satisfactorios debido a los graves efectos secundarios o las infecciones oportunistas que causaban con el uso prolongado.<\/p>\n\n\n\n<p>La terapia con IgIV ha resuelto estos problemas y ha surgido como un tratamiento alternativo m\u00e1s seguro y efectivo con menos efectos secundarios y m\u00e1s manejables.&nbsp;<\/p>\n\n\n\n<p>Para entender c\u00f3mo la IgIV puede ayudarle, primero revisemos brevemente qu\u00e9 causa exactamente las enfermedades ampollosas mucocut\u00e1neas autoinmunes.&nbsp;<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_83 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\/#Autoimmune_Mucocutaneous_Blistering_Diseases_A_Brief_Overview\" >Enfermedades ampollosas mucocut\u00e1neas autoinmunes: una breve descripci\u00f3n general<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\/#Categories_of_Autoimmune_Blistering_Diseases\" >Categor\u00edas de enfermedades ampollosas autoinmunes&nbsp;<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\/#IVIG_and_Autoimmune_Mucocutaneous_Blistering_Diseases\" >IgIV y enfermedades ampollosas mucocut\u00e1neas autoinmunes<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\/#Benefits_of_IVIG_Over_Conventional_Therapies_for_Autoimmune_Mucocutaneous_Blistering_Diseases\" >Beneficios de la IgIV sobre las terapias convencionales para las enfermedades ampollosas mucocut\u00e1neas autoinmunes<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\/#When_Is_IVIG_Recommended_to_Patients_With_Autoimmune_Mucocutaneous_Blistering_Diseases\" >\u00bfCu\u00e1ndo se recomienda la IgIV a pacientes con enfermedades ampollosas mucocut\u00e1neas autoinmunes?<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\" id=\"h-autoimmune-mucocutaneous-blistering-diseases-a-brief-overview\"><span class=\"ez-toc-section\" id=\"Autoimmune_Mucocutaneous_Blistering_Diseases_A_Brief_Overview\"><\/span><strong>Enfermedades ampollosas mucocut\u00e1neas autoinmunes: una breve descripci\u00f3n general<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Las enfermedades ampollosas mucocut\u00e1neas autoinmunes son un grupo de afecciones cut\u00e1neas poco frecuentes y potencialmente mortales que se producen debido a ataques inmunitarios. En esta afecci\u00f3n, el sistema inmunitario que protege al paciente de los pat\u00f3genos inicia una respuesta inmunitaria contra las c\u00e9lulas sanas.&nbsp;<\/p>\n\n\n\n<p>En las enfermedades ampollosas autoinmunes, el sistema inmunitario identifica err\u00f3neamente las prote\u00ednas que unen la piel y las mucosas como material extra\u00f1o e inicia una respuesta inmunitaria contra ellas. Los autoanticuerpos producidos durante esta respuesta atacan estas prote\u00ednas y causan ampollas y erosiones en la piel, la boca, los ojos, la garganta y otras superficies mucosas.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-categories-of-autoimmune-blistering-diseases-nbsp\"><span class=\"ez-toc-section\" id=\"Categories_of_Autoimmune_Blistering_Diseases\"><\/span><strong>Categor\u00edas de enfermedades ampollosas autoinmunes&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Las siguientes son las afecciones o enfermedades de la piel que se incluyen en la <a href=\"https:\/\/www.clevelandclinicmeded.com\/medicalpubs\/diseasemanagement\/dermatology\/blistering-diseases\/\">categor\u00eda<\/a> de los AMBD:&nbsp;<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-1-pemphigus-vulgaris\">1. <strong>P\u00e9nfigo vulgar<\/strong><\/h4>\n\n\n\n<p>Se trata de una enfermedad autoinmune mucocut\u00e1nea potencialmente mortal que provoca ampollas dolorosas y erosiones en la piel y las membranas mucosas, especialmente en la boca.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-2-bullous-pemphigoid\">2. <strong>Penfigoide ampolloso<\/strong><\/h4>\n\n\n\n<p>Esta afecci\u00f3n generalmente afecta a adultos mayores y causa ampollas grandes y tensas en la piel, a menudo precedidas de picaz\u00f3n y enrojecimiento.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-3-mucous-membrane-pemphigoid-mmp\">3. <a href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/mucous-membrane-pemphigoid-everything-you-need-to-know\/\"><strong>Penfigoide de las membranas mucosas<\/strong><\/a><strong> (MMP)<\/strong><\/h4>\n\n\n\n<p>Tambi\u00e9n conocida como penfigoide cicatricial, esta afecci\u00f3n afecta principalmente las membranas mucosas de la boca, la nariz, los genitales y los ojos. La cicatrizaci\u00f3n causada por llagas en los ojos puede provocar ceguera en algunos pacientes.&nbsp;<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-4-pemphigus-foliaceus\">4. <strong>P\u00e9nfigo foli\u00e1ceo<\/strong><\/h4>\n\n\n\n<p>Esta afecci\u00f3n leve de la piel provoca ampollas superficiales que a menudo comienzan en la cara y el cuero cabelludo.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-5-paraneoplastic-pemphigus\">5. <strong>P\u00e9nfigo paraneopl\u00e1sico<\/strong><\/h4>\n\n\n\n<p>Esta afecci\u00f3n de la piel es una forma rara y grave y a menudo est\u00e1 asociada con enfermedades subyacentes como linfoma o leucemia.&nbsp;<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-6-dermatitis-herpetiformis\"><strong>6. Dermatitis herpetiforme<\/strong><\/h4>\n\n\n\n<p>Aunque se asocia principalmente con la enfermedad cel\u00edaca, esta afecci\u00f3n implica la formaci\u00f3n de ampollas con picaz\u00f3n intensa y peque\u00f1as protuberancias (p\u00e1pulas), que suelen aparecer sim\u00e9tricamente en zonas como los codos, las rodillas, los gl\u00fateos, la espalda o el cuero cabelludo. Estos problemas cut\u00e1neos se deben a la deposici\u00f3n de anticuerpos de inmunoglobulina A (IgA) en la piel.<\/p>\n\n\n\n<p>Las enfermedades ampollosas autoinmunes son debilitantes y pueden causar dolor, dificultad para comer e incluso ceguera si no se tratan adecuadamente.&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-1e432803d7afd5b1dc5576deb392c56a\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga autorizaci\u00f3n previa para IgIV\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Programar una consulta<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-ivig-and-autoimmune-mucocutaneous-blistering-diseases\"><span class=\"ez-toc-section\" id=\"IVIG_and_Autoimmune_Mucocutaneous_Blistering_Diseases\"><\/span><strong>IgIV y enfermedades ampollosas mucocut\u00e1neas autoinmunes<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"280\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/nurse-ivig-home.jpg\" alt=\"Nurse setting up IVIG at home\" class=\"wp-image-27226\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/nurse-ivig-home.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/nurse-ivig-home-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/nurse-ivig-home-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/nurse-ivig-home-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/nurse-ivig-home-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/nurse-ivig-home-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/nurse-ivig-home-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p>La terapia con IgIV puede ayudar a los pacientes con enfermedades ampollosas mucocut\u00e1neas autoinmunes al modular su sistema inmunitario hiperactivo. Durante esta terapia, <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/immunoglobulins-ig\/\">anticuerpos<\/a> (preparados a partir del plasma sangu\u00edneo donado) se administran por v\u00eda intravenosa en el cuerpo del paciente.\u00a0<\/p>\n\n\n\n<p>Aunque el efecto terap\u00e9utico exacto de la IgIV en los AMBD a\u00fan no est\u00e1 claro, las investigaciones indican que funciona en <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7577376\/#:~:text=Bullous%20pemphigoid%20(BP)%20is%20an,accelerating%20degradation%20of%20pathogenic%20IgG.\">varias maneras<\/a>:<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-it-neutralizes-the-effects-of-autoantibodies\"><strong>Neutraliza los efectos de los autoanticuerpos<\/strong><\/h4>\n\n\n\n<p>La IgIV proporciona una amplia gama de anticuerpos que <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554446\/\">neutralizar los efectos de los autoanticuerpos<\/a> Producidos por el sistema inmunitario. Estos anticuerpos se unen a los autoanticuerpos da\u00f1inos, impidi\u00e9ndoles atacar a las c\u00e9lulas sanas y reduciendo la gravedad de la enfermedad.&nbsp;<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-it-modulates-immune-response\"><strong>Modula la respuesta inmune<\/strong><\/h4>\n\n\n\n<p>La IgIV tiene efectos inmunomoduladores, lo que significa que tiene la capacidad de regular el sistema inmunitario. La IgIV modula la respuesta inmunitaria mediante <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554446\/\">suprimiendo la producci\u00f3n de autoanticuerpos<\/a> y promover la expansi\u00f3n de las c\u00e9lulas T reguladoras para mantener el sistema inmunol\u00f3gico bajo control.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-it-reduces-inflammation\"><strong>Reduce la inflamaci\u00f3n<\/strong><\/h4>\n\n\n\n<p>La IgIV es conocida por sus efectos antiinflamatorios que <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554446\/\">regular a la baja la producci\u00f3n de citocinas<\/a> (una prote\u00edna se\u00f1alizadora que impulsa la inflamaci\u00f3n). La reducci\u00f3n de la inflamaci\u00f3n ayuda a aliviar la hinchaz\u00f3n, el enrojecimiento y el dolor asociados con las ampollas.&nbsp;<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-it-block-fc-receptors\"><strong>Bloquea los receptores Fc<\/strong><\/h4>\n\n\n\n<p>La IgIV inhibe la <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554446\/\">Respuesta inmune manifiesta mediante el bloqueo de los receptores Fc<\/a> en la superficie de las c\u00e9lulas inmunes como las c\u00e9lulas T, B y dendr\u00edticas.&nbsp;<\/p>\n\n\n\n<p>Los receptores Fc de las c\u00e9lulas inmunitarias suelen ayudar a identificar y eliminar sustancias nocivas. Sin embargo, en las enfermedades ampollosas autoinmunes, estos receptores atacan err\u00f3neamente la piel y las mucosas del propio organismo, consider\u00e1ndolas amenazas. La terapia con inmunoglobulina intravenosa (IVIG) puede mitigar este efecto al bloquear los receptores Fc, previniendo as\u00ed estos ataques err\u00f3neos.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-benefits-of-ivig-over-conventional-therapies-for-autoimmune-mucocutaneous-blistering-diseases\"><span class=\"ez-toc-section\" id=\"Benefits_of_IVIG_Over_Conventional_Therapies_for_Autoimmune_Mucocutaneous_Blistering_Diseases\"><\/span><strong>Beneficios de la IgIV sobre las terapias convencionales para las enfermedades ampollosas mucocut\u00e1neas autoinmunes<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La IgIV ofrece varias ventajas a los pacientes en comparaci\u00f3n con las terapias convencionales. Por ejemplo:<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-1-it-is-a-safe-alternative-with-fewer-side-effects\">1. <strong>Es una alternativa segura con menos efectos secundarios.<\/strong><\/h4>\n\n\n\n<p>En comparaci\u00f3n con las terapias convencionales, la IgIV generalmente es bien tolerada y no causa efectos secundarios o estos son muy escasos, y suelen ser leves y f\u00e1cilmente controlables.&nbsp;<\/p>\n\n\n\n<p>Un estudio publicado en&nbsp;<a href=\"https:\/\/www.pnas.org\/doi\/10.1073\/pnas.2317762121\"><em>PNAS<\/em><\/a><em> <\/em>Se realiz\u00f3 un seguimiento de 21 pacientes con p\u00e9nfigo vulgar (PV) durante 20 a\u00f1os, todos tratados con IgIV como \u00fanico tratamiento. Los resultados mostraron que 57% de los pacientes permanecieron libres de reca\u00eddas durante dos d\u00e9cadas, mientras que 29% experimentaron breves reca\u00eddas provocadas por estr\u00e9s o por la infecci\u00f3n\/vacunaci\u00f3n por COVID-19, pero se recuperaron r\u00e1pidamente con tratamiento adicional con IgIV. Adem\u00e1s, no se reportaron efectos secundarios graves de la IgIV.&nbsp;<\/p>\n\n\n\n<p>Los hallazgos sugieren que la IgIV puede ayudar a restablecer el equilibrio del sistema inmunitario y ofrecer esperanzas de remisi\u00f3n a largo plazo. Tambi\u00e9n proporciona informaci\u00f3n valiosa sobre c\u00f3mo controlar las enfermedades ampollosas autoinmunes como la policitemia vera.<\/p>\n\n\n\n<div  id=\"call-to-action-0b87872b695aa181c8f8f4985530fc2e\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tHabla con un especialista\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAcerca de la asistencia para copagos\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-2-it-is-more-effective-than-conventional-treatments\"><strong>2. Es m\u00e1s eficaz que los tratamientos convencionales.<\/strong><\/h4>\n\n\n\n<p>La IgIV es m\u00e1s <a href=\"https:\/\/www.mdpi.com\/1648-9144\/59\/7\/1265\">eficaz<\/a> que los corticosteroides y los agentes inmunosupresores. Por ejemplo, un <a href=\"https:\/\/cdn-uat.mdedge.com\/files\/s3fs-public\/Document\/September-2017\/CT093050264.pdf\">informe de caso<\/a> El estudio de una mujer de 78 a\u00f1os con AMBD mostr\u00f3 que una semana de tratamiento con IgIV mejor\u00f3 significativamente sus s\u00edntomas; las ampollas y las lesiones sanaron m\u00e1s r\u00e1pido y no aparecieron nuevas lesiones.&nbsp;<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-3-it-improves-quality-of-life\">3. <strong>Mejora la calidad de vida<\/strong><\/h4>\n\n\n\n<p>La IgIV no s\u00f3lo <a href=\"https:\/\/www.medicaljournals.se\/acta\/content\/html\/10.2340\/00015555-1471\">Elimina los s\u00edntomas cl\u00ednicos con el tiempo<\/a> Pero tambi\u00e9n reduce la necesidad de otros medicamentos. Adem\u00e1s, mejor\u00f3 la calidad de vida, y muchos informaron que pod\u00edan realizar sus actividades diarias con mayor comodidad despu\u00e9s del tratamiento con IgIV.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-when-is-ivig-recommended-to-patients-with-autoimmune-mucocutaneous-blistering-diseases\"><span class=\"ez-toc-section\" id=\"When_Is_IVIG_Recommended_to_Patients_With_Autoimmune_Mucocutaneous_Blistering_Diseases\"><\/span><strong>\u00bfCu\u00e1ndo se recomienda la IgIV a pacientes con enfermedades ampollosas mucocut\u00e1neas autoinmunes?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La IgIV generalmente se recomienda como tratamiento alternativo para pacientes con enfermedades ampollosas mucocut\u00e1neas autoinmunes cuando:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Las terapias est\u00e1ndar, como los corticosteroides o los agentes inmunosupresores, son refractarias o est\u00e1n contraindicadas.<\/li>\n\n\n\n<li>Los pacientes no responden a la terapia est\u00e1ndar o presentan reca\u00eddas bajo el tratamiento est\u00e1ndar.<\/li>\n\n\n\n<li>Los pacientes sufren efectos secundarios graves de otros medicamentos.<\/li>\n\n\n\n<li>El estado del paciente est\u00e1 progresando r\u00e1pidamente.<\/li>\n<\/ol>\n\n\n\n<p>En resumen, la IgIV puede ser un tratamiento seguro y eficaz para pacientes con enfermedades ampollosas autoinmunes, y aquellos que no obtienen resultados prometedores con las terapias convencionales pueden explorar reg\u00edmenes de tratamiento con IgIV con su proveedor de atenci\u00f3n m\u00e9dica.<\/p>\n\n\n\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>Las investigaciones han demostrado que la IgIV es una opci\u00f3n de tratamiento prometedora para pacientes con enfermedades ampollosas mucocut\u00e1neas autoinmunes (AMBD), un grupo de afecciones que causan ampollas dolorosas, llagas y, a veces, cicatrices en la piel o las membranas mucosas.\u00a0<\/p>","protected":false},"author":13,"featured_media":27225,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[7],"tags":[17],"class_list":["post-27223","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ivig","tag-dr-saba-rassouli"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IVIG for Autoimmune Mucocutaneous Blistering Diseases<\/title>\n<meta name=\"description\" content=\"Learn about how IVIG can be used to treat autoimmune mucocutaneous blistering diseases. We discuss the benefits of IVIG over other therapies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IVIG for Autoimmune Mucocutaneous Blistering Diseases\" \/>\n<meta property=\"og:description\" content=\"Learn about how IVIG can be used to treat autoimmune mucocutaneous blistering diseases. We discuss the benefits of IVIG over other therapies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-25T21:43:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-03T20:26:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Saba Rassouli, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Saba Rassouli, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\\\/\"},\"author\":{\"name\":\"Dr. Saba Rassouli, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/f70b3467e035aab4ae14bdadd64c5c01\"},\"headline\":\"IVIG for Autoimmune Mucocutaneous Blistering Diseases\",\"datePublished\":\"2025-03-25T21:43:02+00:00\",\"dateModified\":\"2025-04-03T20:26:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\\\/\"},\"wordCount\":1055,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/ivig-blistering-diseases.jpg\",\"keywords\":[\"Dr. Saba Rassouli\"],\"articleSection\":[\"IVIG\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\\\/\",\"name\":\"IVIG for Autoimmune Mucocutaneous Blistering Diseases\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/ivig-blistering-diseases.jpg\",\"datePublished\":\"2025-03-25T21:43:02+00:00\",\"dateModified\":\"2025-04-03T20:26:10+00:00\",\"description\":\"Learn about how IVIG can be used to treat autoimmune mucocutaneous blistering diseases. We discuss the benefits of IVIG over other therapies.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/ivig-blistering-diseases.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/ivig-blistering-diseases.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Doctor consulting with patient who has autoimmune blistering disease\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IVIG for Autoimmune Mucocutaneous Blistering Diseases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/f70b3467e035aab4ae14bdadd64c5c01\",\"name\":\"Dr. Saba Rassouli, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"caption\":\"Dr. Saba Rassouli, PharmD\"},\"description\":\"Dr. Saba Rassouli, PharmD was born and raised in Iran. She received her pharmacy degree from Marshall B. Ketchum University in 2022, where she graduated cum laude. The most rewarding part of her job is having the opportunity to care for each patient as if they were family and hearing about how happy and satisfied they are with the services provided by AmeriPharma. In her free time, she likes to go on walks, read books, and try different restaurants and foods.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/saba-rassouli\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IgIV para enfermedades ampollosas mucocut\u00e1neas autoinmunes","description":"Aprenda c\u00f3mo la IgIV puede utilizarse para tratar enfermedades ampollosas mucocut\u00e1neas autoinmunes. Analizamos sus beneficios frente a otras terapias.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\/","og_locale":"es_MX","og_type":"article","og_title":"IVIG for Autoimmune Mucocutaneous Blistering Diseases","og_description":"Learn about how IVIG can be used to treat autoimmune mucocutaneous blistering diseases. We discuss the benefits of IVIG over other therapies.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2025-03-25T21:43:02+00:00","article_modified_time":"2025-04-03T20:26:10+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases.jpg","type":"image\/jpeg"}],"author":"Dr. Saba Rassouli, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Saba Rassouli, PharmD","Est. reading time":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\/"},"author":{"name":"Dr. Saba Rassouli, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/f70b3467e035aab4ae14bdadd64c5c01"},"headline":"IVIG for Autoimmune Mucocutaneous Blistering Diseases","datePublished":"2025-03-25T21:43:02+00:00","dateModified":"2025-04-03T20:26:10+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\/"},"wordCount":1055,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases.jpg","keywords":["Dr. Saba Rassouli"],"articleSection":["IVIG"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\/","url":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\/","name":"IgIV para enfermedades ampollosas mucocut\u00e1neas autoinmunes","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases.jpg","datePublished":"2025-03-25T21:43:02+00:00","dateModified":"2025-04-03T20:26:10+00:00","description":"Aprenda c\u00f3mo la IgIV puede utilizarse para tratar enfermedades ampollosas mucocut\u00e1neas autoinmunes. Analizamos sus beneficios frente a otras terapias.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases.jpg","width":1280,"height":853,"caption":"Doctor consulting with patient who has autoimmune blistering disease"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-autoimmune-mucocutaneous-blistering-diseases\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspe.wpenginepowered.com\/es\/"},{"@type":"ListItem","position":2,"name":"IVIG for Autoimmune Mucocutaneous Blistering Diseases"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/f70b3467e035aab4ae14bdadd64c5c01","name":"Dra. Saba Rassouli, Farmac\u00e9utica","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","caption":"Dr. Saba Rassouli, PharmD"},"description":"La Dra. Saba Rassouli, doctora en farmacia, naci\u00f3 y creci\u00f3 en Ir\u00e1n. Obtuvo su t\u00edtulo en farmacia en la Universidad Marshall B. Ketchum en 2022, donde se gradu\u00f3 con honores. Lo m\u00e1s gratificante de su trabajo es tener la oportunidad de atender a cada paciente como si fuera de su familia y escuchar lo contentos y satisfechos que est\u00e1n con los servicios de AmeriPharma. En su tiempo libre, le gusta pasear, leer y probar diferentes restaurantes y comidas.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/saba-rassouli\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Saba Rassouli, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/saba-rassouli\/"},"uagb_comment_info":0,"uagb_excerpt":"Research has shown that IVIG is a promising treatment option for patients with autoimmune mucocutaneous blistering diseases (AMBDs), a group of conditions that cause painful blisters, sores, and sometimes scarring on the skin or mucous membranes.\u00a0","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/03\/ivig-blistering-diseases.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Saba Rassouli, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/saba-rassouli\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/ivig\/\" rel=\"category tag\">IVIG<\/a>","rttpg_excerpt":"Research has shown that IVIG is a promising treatment option for patients with autoimmune mucocutaneous blistering diseases (AMBDs), a group of conditions that cause painful blisters, sores, and sometimes scarring on the skin or mucous membranes.\u00a0","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27223","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=27223"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27223\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/27225"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=27223"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=27223"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=27223"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}